Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Best Practice & Research. Clinical Rheumatology|January 24, 2012
Joint appendages: the structures which have historically been overlooked in arthritis research and therapy developmentZoe Ash, Dennis McGonagleExpert Opinion on Biological Therapy|August 2, 2012
The role of tocilizumab in the management of rheumatoid arthritisZoe Ash, Paul EmeryAnnals of Medicine|January 20, 2011
Golimumab - a new tool in the armoury against inflammatory arthritisZoe Ash, Paul EmeryThe Journal of Rheumatology|November 3, 2012
GRAPPA Trainees Symposium 2011: a report from the GRAPPA 2011 annual meetingZoe Ash, Christopher T RitchlinAnnals of the Rheumatic Diseases|February 23, 2011
The early phase of psoriatic arthritisDennis McGonagle, Zoe Ash, Laura Dickie, et al.Dermatology (Basel, Switzerland)|February 4, 2012
Linear pitting and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in comparison to psoriatic arthritisNatalia Palmou, Helena Marzo-Ortega, Zoe Ash, et al.Dermatology (Basel, Switzerland)|July 28, 2011
Optical coherence tomography: a new tool to assess nail disease in psoriasis?Sibel Zehra Aydin, Zoe Ash, Francesco Del Galdo, et al.Annals of the Rheumatic Diseases|August 2, 2011
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritisZoe Ash, Cécile Gaujoux-Viala, Laure Gossec, et al.Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C)Khizer Iqbal, Saptarshi Sinha, Paula David, et al.Ebiomedicine|May 9, 2024
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)Paula David, Saptarshi Sinha, Khizer Iqbal, et al.Pageof 1